The objective of this study is to conduct exploratory analysis of the potential association between treatment with pioglitazone and risk of cancer at sites other than bladder using information available from a variety of KPNC electronic data sources.
Cohort Study of Pioglitazone and Cancer Incidence in Patients with Diabetes Mellitus
Investigator: Ferrara, Assiamira
Funder: Takeda Pharmaceuticals North America
